Patents by Inventor Jonathan Waxman

Jonathan Waxman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection and prediction of physiological events in people with sleep disordered breathing using a LAMSTAR neural network
    Patent number: 8775340
    Abstract: Apparatus and methods are disclosed for generating and outputting physiological event results from physiological data related to a patient. Physiological event results include results predicting and/or detecting individual physiological events related to a medical condition of the patient.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: July 8, 2014
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Jonathan Waxman, Daniel Graupe, David W. Carley
  • Detection and Prediction of Physiological Events in People with Sleep Disordered Breathing Using a LAMSTAR Neural Network
    Publication number: 20110251985
    Abstract: Apparatus and methods are disclosed for generating and outputting physiological event results from physiological data related to a patient. Physiological event results include results predicting and/or detecting individual physiological events related to a medical condition of the patient.
    Type: Application
    Filed: December 15, 2009
    Publication date: October 13, 2011
    Applicant: The Board of Trustees of the University of Illinios
    Inventors: Jonathan Waxman, Daniel Graupe, David W. Carley
  • METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20110189669
    Abstract: The current invention provides a method for aiding in the assessment of prostate cancer (including metastatic prostate cancer) and/or benign prostate hyperplasia in a patient, wherein the method comprises the step of determining the level of Glycine N-methyltransferase (GNMT) nucleic acid and/or protein in a sample from the patient. The invention also provides compounds that target Glycine N-methyltransferase (GNMT) protein and/or nucleic acid for use in treating prostate cancer. Also provided are screening methods for selecting a compound considered to be useful in treating prostate cancer, comprising the steps of determining the ability of a test compound to reduce GNMT activity and selecting a compound that reduces GNMT activity. The invention also provides methods for aiding in the diagnosis of prostate cancer in a patient comprising obtaining a sample from the patient and assessing said sample for a marker of GNMT activity.
    Type: Application
    Filed: June 19, 2009
    Publication date: August 4, 2011
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Laki Buluwela, Jonathan Waxman, Simak Ali, Sarah Ngan